N-docosanoylsphingosine

Metabolite details

Identifier

KEPQASGDXIEOIL-GLQCRSEXSA-N

InChI Key

KEPQASGDXIEOIL-GLQCRSEXSA-N

IUPAC name

N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]docosanamide

Preferred name

N-docosanoylsphingosine

INN name

—

Synonym

N-behenoylsphingosine

ChEBI

CHEBI:72966

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates
• Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19

Observed in differential profiles

• Control_vs_AONFH_Stage_III_IV
• Control_vs_OXPA_Treatment
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Knockdown_vs_Control
• Knockdown_vs_Control
• Control_vs_Palmitate
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT
• Mild_vs_Severe